Named on 2 rounds in the feed, most often in Healthtech.
Rounds from 2019-05-20 to 2022-12-14
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$47.8M
across 2 rounds
CO-INVESTORS
7
named beside it
Named on 2 rounds in the feed, most often in Healthtech.
Rounds from 2019-05-20 to 2022-12-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
STORM Therapeutics STORM Therapeutics develops RNA modifying enzyme inhibitors for the treatment of sarcomas. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2022-12-14 | [ PART ] |
STORM Therapeutics STORM Therapeutics develops RNA modifying enzyme inhibitors for the treatment of sarcomas. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $17.8M | 2019-05-20 | [ PART ] |